Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
NCT ID: NCT02966951
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
10 participants
INTERVENTIONAL
2017-01-17
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
NCT02963727
Mesenchymal Stem Cells in Knee Cartilage Injuries
NCT02118519
Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA
NCT02351011
Autologous Micro-fragmented Adipose Tissue Injection for Knee Osteoarthritis
NCT03788265
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis
NCT01809769
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adipose tissue mesenchymal stem cell
Intra-articular adipose tissue derived mesenchymal stem cell injection will be given for each patient in 2 doses, 50 million of ATMSC in each dose
Adipose tissue derived mesenchymal stem cell
Intra-articular adipose tissue derived mesenchymal stem cell injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adipose tissue derived mesenchymal stem cell
Intra-articular adipose tissue derived mesenchymal stem cell injection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Willing to participate by signing the informed consent
Exclusion Criteria
* Oral anticoagulants or heparin therapy
* Heart failure or arrhythmia
* Body Mass Index \> 35
* Uncontrolled Diabetes Mellitus.
* Evidence of Infectious Diseases.
* Active infection
* Malignancy
* Pregnancy
* Anemia less than 11g/dl or thrombocytopenia less than 100,000 or leucopenia less than 3000.
* Unreliable patients
* Non-resident in Jordan
42 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hanan Jafar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanan Jafar
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdallah Awidi, MD
Role: STUDY_DIRECTOR
Cell Therapy Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cell Therapy Center
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATKneeUJCTC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.